Background Janus kinase inhibitors (JAKis) are emerging therapies for SLE, but concerns regarding thromboembolic risk persist ...
A research team led by Profs. Jascha Repp, Rupert Huber, Franz Giessibl, and Klaus Richter at RUN, as well as a team led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results